06:45 EST Merck (MRK) to acquire Cidara Therapeutics (CDTX) for $221.50 per share in cash, or $9.2B
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK:
- Merck close to deal to acquire Cidara Therapeutics, FT reports
- Merck call volume above normal and directionally bullish
- Nike upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
- Scotiabank starts 10 large cap drugmakers with ‘out-of-consensus’ positive view
- Merck initiated with an Outperform at Scotiabank